UK and EU policy

Our work

Data sharing in public health emergencies

Research is an essential part of being ready for and responding to public health emergencies, like COVID-19 and Ebola.

Good Clinical Trials Collaborative

Randomised clinical trials are essential to advancing evidence-based medicine and improving human health. But new guidelines are needed, which is why we've launched the Good Clinical Trials Collaborative. 

Access to healthcare interventions

Everyone should have access to the life-changing benefits of medicines and other healthcare interventions, like vaccines, diagnostics and therapies.

Open research

We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.


Knowledge and understanding don’t stop at borders. We worked with the UK government and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.

Emerging science and technologies

Emerging science and technologies, such as human genome editing and gene drive, could provide new solutions to health problems.

Patient data in research

Patient data is hugely valuable for research. But the value of that data can only be unlocked if concerns about patient privacy are taken seriously.

The R&D decade: making the case for government investment

We want to secure the investment in research promised by the UK government to overcome the biggest challenges in the world, such as climate change and epidemics.

EU copyright law reform

The European Commission has published a proposal to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.

Research involving animals

Almost every major breakthrough in human and veterinary medicine has depended on the use of animals to research, develop or test new therapies.

Mitochondrial donation

Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.

EU medical devices regulations

The European Union is revising regulations governing the manufacture and sale of medical devices.

Expert Advisory Group on Data Access

The Expert Advisory Group on Data Access promoted good working practices, consistent governance and transparent decision making for managing and using data from cohort studies.

Accelerated Access Review

The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.


Report 14 January 2021 Updated 14 January 2021

What does the UK-EU deal mean for research and health?

DownloadPDF 126KB

Our analysis of the post-Brexit trade deal and how it delivers for the UK-EU research sector.

Report 5 October 2020 Updated 5 October 2020

The UK’s role in global research: executive summary

DownloadPDF 165KB

This report sets out principles and actions for the UK Government to achieve its aim of making the UK a global science superpower.

Report 5 October 2020 Updated 10 December 2020

The UK’s role in global research

DownloadPDF 417KB

This report sets out principles and actions for the UK Government to achieve its aim of making the UK a global science superpower.

More reports

Briefings and responses

Consultation response 1 September 2019 Updated 4 December 2019

Priorities for the 2019 spending round

DownloadPDF 157KB
Consultation response 1 May 2019 Updated 4 December 2019

Future frameworks for international collaboration on research

DownloadPDF 197KB
Consultation response 1 April 2019 Updated 4 December 2019

Education inspection framework 2019

DownloadPDF 95KB
More briefings and responses